ASHAR BHAVESH (Chief Commercial Officer) reported 3 transactions at SPRINGWORKS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/7/2025ACC: 0001104659-25-001778
Officer· Chief Commercial Officer
Since Mar 2021
-10.58K
Net shares
Net seller
$405.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
10.58K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−4.47K
Price / share
$38.19
Trade value
$170.90K
% of position
7.9%
1/4/2025
56.33K→51.85K
Common Stock
Direct
Shares
−3.83K
Price / share
$38.19
Trade value
$146.08K
% of position
7.4%
1/5/2025
51.85K→48.03K
Common Stock
Direct
Shares
−2.28K
Price / share
$38.86
Trade value
$88.76K
% of position
4.8%
1/6/2025
48.03K→45.75K
Total
Net shares
−10.58K
Net value
-$405.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/4/2025 | F · Tax Withholding | −4.47K | $38.19 | $170.90K | 7.9% | 56.33K | 51.85K |
| Common Stock Direct | 1/5/2025 | F · Tax Withholding | −3.83K | $38.19 | $146.08K | 7.4% | 51.85K | 48.03K |
| Common Stock Direct | 1/6/2025 | F · Tax Withholding | −2.28K | $38.86 | $88.76K | 4.8% | 48.03K | 45.75K |
| Total | −10.58K | -$405.73K | ||||||
Derivative Transactions0
No derivative transactions reported